(Q38077164)

28 August 2017

1 reference

title

MRI of ovarian masses (English)

1 reference

28 August 2017

author

Hebert Alberto Vargas

series ordinal

1

object named as

Hebert Alberto Vargas

1 reference

28 August 2017

3

Evis Sala

1 reference

28 August 2017

2

Tristan Barrett

1 reference

28 August 2017

publication date

1 February 2013

1 reference

Journal of Magnetic Resonance Imaging

28 August 2017

published in

1 reference

28 August 2017

volume

37

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

265-281

1 reference

Magnetic resonance imaging of the female pelvis

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

MR imaging of the sonographically indeterminate adnexal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Endometriosis: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Imaging evaluation of ovarian masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Staging ovarian cancer: role of imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

ESUR guidelines: ovarian cancer staging and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Tumor markers in the management of patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Ovarian cancer: the role of functional imaging as an end point in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Early diagnosis of ovarian carcinoma: is a solution in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23721

21 January 2018

Identifiers

DOI

10.1002/JMRI.23721

1 reference

28 August 2017

1 reference